“…Nevertheless, no anti-tumor response can be triggered due to the immunosuppressive TME (15). Indeed, a lower density of immune cells has been observed in prostatic adenocarcinomas compared to benign nodular hyperplasia of the prostate (16). Anti-tumor CD8+ T cells are also suppressed by the depletion of arginase and tryptophan from the TME after upregulation of secretion of nitrous oxide synthase and indoleamine 2,3-dioxygenase (IDO) by myeloid-derived suppressor cells (MDSCs) (16), or by the presence of a large amount of regulatory T cells (Tregs) compared to other cancers (17), and other immunosuppressive cells Abbreviations: APC, antigen-presenting cell; bsAb, bispecific antibodies; BT, brachytherapy; CAR, chimeric antigen receptor; CSF1, colony-stimulating factor 1; CTLA-4, cytotoxic T lymphocyte antigen; cTL, cytotoxic T lymphocyte; DC, dendritic cell; DHT, dihydrotestosterone; EBRT, external beam radiation therapy; EORTC, European Organization for Research and Treatment of Cancer; EMT, epithelial-mesenchymal transition; ESTRO, European Society for Radiotherapy and Oncology; EV, extracellular vesicle; HIF-1, hypoxia-inducible factor 1; HLA, human leukocyte antigen; HR, hazard ratio; ICI, immune checkpoint inhibitors; IFN, interferon; mCRPC, metastatic castration-resistant prostate cancer; MDSC, myeloid-derived suppressor cell; MHC, major histocompatibility complex; miRNA, microRNA; NK, natural killer; NKT, natural killer T; ORR, objective response rate; PAP, prostatic acid phosphatase; PCa, prostate cancer; PD-1, programmed cell death 1; PD-L1/2, programmed cell death-ligand 1/2; POLD1, DNA polymerase delta; POLE, polymerase epsilon; PSA, prostate-specific antigen; PSMA, prostate-specific membrane antigen; SABR, stereotactic ablative radiotherapy; SBRT, Stereotactic body radiation therapy; T, T lymphocyte; TAA, tumor associated antigen; TAM, tumor associated macrophage; TCR, t cell receptor; TEX, tumor exosome; TIL, tumor infiltrating lymphocyte; TMB, tumor mutational burden; TME, tumor microenvironment; T reg, regulatory T cell; TSA, tumor specific antigen; VSV, vesicular stomatitis virus.…”